PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 44 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,869,000 | -37.9% | 674,800 | -9.1% | 0.00% | 0.0% |
| Q2 2020 | $11,056,000 | +15.0% | 742,000 | -5.9% | 0.00% | 0.0% |
| Q1 2020 | $9,613,000 | -30.4% | 788,600 | -9.6% | 0.00% | -50.0% |
| Q4 2019 | $13,804,000 | +28.9% | 872,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $10,708,000 | -0.7% | 872,000 | +6.7% | 0.00% | 0.0% |
| Q2 2019 | $10,784,000 | – | 817,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|